Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Anti-inflammatory and anti-mutagenic effect of the YHK phytocompound in hepatocytes: in view of an age-management liver-protecting approach.

Catanzaro R, Celep G, Illuzzi N, Milazzo M, Rastmanesh R, Yaduvanshi SK, He F, Trushin M, Sapienza C, Srivastava N, Marotta F.

Rejuvenation Res. 2014 Apr;17(2):168-71. doi: 10.1089/rej.2013.1492. Epub 2014 Apr 8.

PMID:
24050307
2.

Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP).

Stefano JT, de Oliveira CP, Corrêa-Giannella ML, de Lima VM, de Sá SV, de Oliveira EP, de Mello ES, Giannella-Neto D, Alves VA, Carrilho FJ.

Dig Dis Sci. 2007 Dec;52(12):3448-54. Epub 2007 Mar 30.

PMID:
17394061
3.

Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet.

de Lima VM, de Oliveira CP, Sawada LY, Barbeiro HV, de Mello ES, Soriano FG, Alves VA, Caldwell SH, Carrilho FJ.

Liver Int. 2007 Mar;27(2):227-34.

PMID:
17311618
4.

Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study.

Chande N, Laidlaw M, Adams P, Marotta P.

Dig Dis Sci. 2006 Jul;51(7):1183-9.

PMID:
16944007

Supplemental Content

Loading ...
Support Center